These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 19208985)
1. Multidrug-resistant to extensively drug resistant tuberculosis: what is next? Jain A; Dixit P J Biosci; 2008 Nov; 33(4):605-16. PubMed ID: 19208985 [TBL] [Abstract][Full Text] [Related]
2. Extensively drug-resistant tuberculosis: current challenges and threats. Jain A; Mondal R FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439 [TBL] [Abstract][Full Text] [Related]
3. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. OʼDonnell MR; Pillay M; Pillay M; Werner L; Master I; Wolf A; Mathema B; Coovadia YM; Mlisana K; Horsburgh CR; Padayatchi N J Acquir Immune Defic Syndr; 2015 Aug; 69(5):536-43. PubMed ID: 25886924 [TBL] [Abstract][Full Text] [Related]
4. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737 [TBL] [Abstract][Full Text] [Related]
5. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011. Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089 [TBL] [Abstract][Full Text] [Related]
7. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823 [TBL] [Abstract][Full Text] [Related]
8. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India. Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648 [TBL] [Abstract][Full Text] [Related]
9. [Extensively drug-resistant tuberculosis]. Lange C; Grobusch MP; Wagner D Dtsch Med Wochenschr; 2008 Feb; 133(8):374-6. PubMed ID: 18270922 [TBL] [Abstract][Full Text] [Related]
10. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157 [TBL] [Abstract][Full Text] [Related]
11. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates]. Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903 [TBL] [Abstract][Full Text] [Related]
12. Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis. Ahmad S; Mokaddas E J Infect Public Health; 2014; 7(2):75-91. PubMed ID: 24216518 [TBL] [Abstract][Full Text] [Related]
14. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan. Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924 [TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control. Matteelli A; Migliori GB; Cirillo D; Centis R; Girard E; Raviglion M Expert Rev Anti Infect Ther; 2007 Oct; 5(5):857-71. PubMed ID: 17914919 [TBL] [Abstract][Full Text] [Related]
16. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa. Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012 [TBL] [Abstract][Full Text] [Related]
17. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213 [TBL] [Abstract][Full Text] [Related]
18. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study. Gallo JF; Pinhata JMW; Simonsen V; Galesi VMN; Ferrazoli L; Oliveira RS Clin Microbiol Infect; 2018 Aug; 24(8):889-895. PubMed ID: 29175351 [TBL] [Abstract][Full Text] [Related]
19. Drug Resistance Characteristics of Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045 [No Abstract] [Full Text] [Related]